Patent · US Active

Variant TLR4 nucleic acid and uses thereof

US7498151B2 · kind B2 · utility

1Cited by
0References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 7, 2006
Grant dateMar 3, 2009
Priority date—
Expiry dateSep 7, 2026

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA01K2217/05
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The invention provides methods to identify polymorphisms at the human TLR4 locus, as well as methods to identify individuals at risk of indications that increase their morbidity and mortality.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.